While BAP1’s role as a tumor suppressor is well-established in breast cancer [72], malignant mesothelioma [43, 73], and uveal melanoma [74, 75], its involvement in targeted therapy-induced apoptosis is novel. This evidence concerns the gene BAP1 and breast cancer.